Navigation Links
Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015
Date:12/1/2009

logy and cytology, immunochemistry, infectious immunology, microbiology culture and haematology.

- Market Analysis from 2001 to 2008, including new updated 2008 data.

- Analysis of the leading companies and competitive landscape including 2008 company market share analysis. Key companies covered include F. Hoffmann-La Roche Ltd, Siemens Medical Solutions, Abbott Laboratories, Beckman Coulter, Inc., Biomerieux Sa and Ortho-Clinical Diagnostics Inc.

- Analysis of key IVD pipeline products, new technologies and clinical trials.

- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.

- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the global IVD market.

- Develop a clear knowledge & understanding of the global IVD competitor landscape and how this will change to 2015.

- Identify acquisition opportunities across the global IVD market.

- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Executive Summary

4 Definitions of Markets Covered in This Report

4.1 In Vitro Diagnostics

4.2 Blood Test Reagents

4.3 Clinical Chemistry Test Reagents

4.4 Genetic Test Reagents

4.5 Immunochemistry Test Reagents

4.6 In
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 (HealthDay News) -- A new formulation of ... snorting or injecting the drug has been approved by ... ER and made by Purdue Pharma, the pill is ... drug that blocks the euphoric effects of oxycodone. The ... snorted, dissolved or injected, according to the FDA. ...
(Date:7/24/2014)... for the 4th Annual National Venous Interventional Summit ... VEINS is an established Venous Endovascular Interventional Strategies ... primary aim is to provide a "How To" ... are interested in advancing their knowledge and skills ... developing their own comprehensive venous interventional program. Topics ...
(Date:7/24/2014)... ACRIA & AMIDA CARE TO COHOST WHITE HOUSE ... Save the Dates: August 7th & August 8th* ... Dialogue for Life” forums this August, led by Douglas Brooks, ... National AIDS Policy (ONAP). This will be a wonderful opportunity ... AIDS organizations, consumers and advocates to advance the National HIV/AIDS ...
(Date:7/24/2014)... 24, 2014 National Analysts Worldwide, the ... it will operate globally under the name, NAXION ... woman-owned Employee Stock Ownership Plan (ESOP) organization led by ... Ph.D . The firm guides market strategy in ... , Said McDonald, “We wanted our name to ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 For the first time ... the United States. The Scottish singer first became a known musical ... Talent. Her first song on the show was “I Dreamed a ... has released five studio albums since her time on the reality ... perform in front of her American fans. The tour will kick ...
Breaking Medicine News(10 mins):Health News:FDA Approves Hard-to-Abuse Narcotic Painkiller 2Health News:Preliminary agenda available for 4th VEINS Conference to be held October 9-12 in Chicago 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 3Health News:National Analysts Worldwide Announces a Change of Name to NAXION 2Health News:National Analysts Worldwide Announces a Change of Name to NAXION 3Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 2Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 3Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 4
... developed at UC Irvine that made paralyzed rats walk again ... in humans. , The U.S. Federal Drug Administration has approved ... by Hans Keirstead, co-director of the UCI Sue and Bill ... patients with acute spinal cord injury. , Geron Corp. of ...
... decreased 3.7 points to 45.7 in December, according to the latest ... Harris Interactive(R) on behalf of Spherion Corporation, indicates that workers are ... to find a new job. , , Results ... Sixty-six percent of workers believe ...
... San Antonio Officials with The University of Texas ... $1.2 million gift from the Robert J. Kleberg, Jr. ... to purchase a second generation aberration corrected electron microscope. ... nanotechnology researchers develop new cancer therapies and treatments that ...
... company, will it be a good deal or a bad deal? Fintan Walton, ... companies. , ... Oxford, UK (PRWEB) January 23, 2009 -- If Pfizer and Wyeth merge ... a bad deal? Fintan Walton, PhD, CEO of PharmaVentures, says, ‘This is potentially ...
... scientists will gather in Canberra this week for the ... a homecoming for the ANS which was formally created ... input from ANU. , A total of 535 presentations ... made by neuroscientists throughout the conference, revealing the latest ...
... Your Smile to Fit Your Life -CINCINNATI, Jan. 23 ... advanced innovation in teeth whitening technology: New Crest Whitestrips ... strip to users, teeth, allowing them to easily talk ... The secure fit comes off clean after whitening, ...
Cached Medicine News:Health News:UCI behind world's first embryonic stem cell study in humans 2Health News:Texas Employment Report: Employee Confidence Index Drops 2Health News:UTSA receives $1.2 million gift from Kleberg Foundation 2Health News:Pfizer - Wyeth: Good Deal – Bad Deal? 2Health News:The world's best brains descend on Canberra 2Health News:Crest Whitestrips Introduces a Revolutionary New Teeth Whitening Technology 2Health News:Crest Whitestrips Introduces a Revolutionary New Teeth Whitening Technology 3
(Date:7/24/2014)... -- Decision Resources Group finds that, for the treatment ... France , Germany , ... and the United Kingdom ) hold ... beta2 agonist/inhaled corticosteroid (LABA/ICS) fixed-dose combination (FDC), Relvar (GlaxoSmithKline/Theravance). ... first-line LABA/ICS FDC in the treatment of asthma with ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
(Date:7/24/2014)... -- Boston Children,s Hospital,s Global Pediatric Summit + Awards, ... "Innovation Tank" – a forum designed to give pediatric ... or product solution to a panel of acclaimed judges ... accelerate the innovation and bring it to market. ... 31, will be moderated by Daymond John ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3
... strains of methicillin-resistant Staphylococcus aureus, commonly known as ... to a wavelength of blue light, in a process called ... of print in Photomedicine and Laser Surgery . The ... Number 2) of the peer-reviewed journal published by Mary ...
... January 29 DNA Therapeutics, an emerging,biopharmaceutical company ... announces the successful closing of its Series A,equity ... SEFTI with two of,the previous seed investors, Blue ... invest 2.2 million EUR based on certain milestones ...
Cached Medicine Technology:Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal 2Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal 3DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round 2DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round 3
... Growth hormone (GH) is a monomeric protein ... anterior pituitary gland. GH is released from ... pulsatile manner under the regulatory control of ... [1]. The timing and frequency of GH ...
... (IGF-I or somatomedin C) is a 7.6 kDa ... as a potent mitogen of cellular proliferation, exerting ... In the circulation, IGF-I is bound to IGF-binding ... of IGF-I by modulating the interaction of IGF-I ...
... potent naturally occurring androgen produced from ... 5a-reductase [1]. The concentrations of ... tissues, including genital skin and hair ... apparent association with the nuclear membrane. ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
Medicine Products: